Browsing by Subject Haemophilus influenzae type b

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  

Showing results 1 to 20 of 36  next >
B126_R15-en.pdf.jpg
Accelerating progress towards achievement of Millennium Goal 4 to reduce child mortality: prevention and treatment of pneumonia
Executive Board, 126 ( 2010 )
B126_R15-fr.pdf.jpg
Accélération des progrès pour la réalisation de l’objectif du millénaire pour le développement n°4 tendant à réduire la mortalité des enfants : traitement et prévention de la pneumonie
Conseil exécutif, 126 ( 2010 )
B126_R15-sp.pdf.jpg
Acelerar los progresos hacia el logro del Objetivo de Desarrollo del Milenio 4 para reducir la mortalidad infantil: prevención y tratamiento de la neumonía
Consejo Ejecutivo, 126 ( 2010 )
EMHJ_2014_20_7_431_441.pdf.jpg
Childhood very severe pneumonia and meningitisrelated hospitalization and death in Yemen, before and after introduction of H. influenzae type b (Hib)vaccine
Alfrayh, A.; Banajeh, S. M.; Ashoor, O.; Al Magramy, A. S. ( 2014 )
Abstract

لقد أدرج لقاح المستدمية المنزلية من النمط "بي" في البرنامج اليمني للتمنيع ‏في عام 2005 . وتقارن هذه الدراسة بين معدلات الإدخال في المستشفيات ‏والوفيات ذات الصلة بالالتهاب الرئوي الشديد جدا والالتهاب السحائي الناجم عن ‏جميع الأسباب قبل وبعد إدخال لقاح المستدمية النزلية المتقارن من النمط "بي"، ‏وتعرض نتائج الترصد لالتهاب السحايا الجرثومي في عام 2010 . وهي دراسة ‏استعادية أجريت على البيانات التي جمعت في الفترة 2000 - 2010 وشملت ‏جميع الأطفال الذين تراوحت أعمارهم بين شهرين و 60 شهرا في المستشفى ‏الرئيسي لطب الأطفال في صنعاء. وقد اتضح وجود انخفاضات يعتد بها إحصائيا ‏ومثيرة للاهتمام في معدلات الإدخال إلى المستشفى والموت الناجم عن جميع أسباب ‏التهابات السحايا في الفترة التي سبقت إدخال اللقاح مقارنة بالفترة التي تلت إدخال ‏اللقاح. إلا أن معدل الإدخال إلى المستشفى والوفيات بسبب الالتهاب الرئوي الشديد ‏جدا لم يتحسن إلا قليلا، وكانت هناك بينات على تناقص، ولكن دون أن يكون له ميل ‏يعتد به إحصائيا، مما يدل على أن الالتهاب الرئوي الشديد جدا كان بمثابة نقطة ‏نهائية غير نوعية تترافق بأسباب متعددة للأمراض [منها جرثومي ومنها فيروسي]. ‏ولايزال الالتهاب الرئوي الشديد جدا هو السبب الأكثر انتشارا للأمراض الشديدة ‏وللموت بين صغار الأطفال، ولاسيما من يقل عمره عن 12 شهرا

ABSTRACT Haemophilus influenzae type b (Hib) vaccine was included in the Yemen immunization programme in 2005. This study compared the rates of very severe pneumonia and all-cause meningitis hospitalization and death, before and after introduction of conjugate Hib vaccine, and reports the results of the 2010 bacterial meningitis surveillance. A retrospective analysis was made of data collected for 2000–2010 for all children aged 2–60 months in the main children’s hospital in Sana’a. Compared with the pre-Hib vaccination period, the post-Hib period showed significant and impressive reductions in the rates of hospitalization and death for all-cause meningitis. However, hospitalization and death for very severe pneumonia improved only modestly, and there was evidence of a decreasing but non-significant trend indicting that very severe pneumonia was a non-specific endpoint with multi-etiologies (both viral and bacterial). Very severe pneumonia remains the leading cause of severe morbidity and death for young children, particularly those aged < 12 months.

RÉSUMÉ Le vaccin contre Haemophilus influenzae type b (Hib) a été inclus dans le programme de vaccination du Yémen en 2005. La présente étude a comparé les taux d'hospitalisation et de décès dus à une pneumonie très sévère et à une méningite toutes causes confondues, avant et après l'introduction du vaccin Hib conjugué ; elle a par ailleurs présenté les résultats de la surveillance de la méningite bactérienne de 2010. Une analyse rétrospective a été menée afin de recueillir des données sur la période de 2000 à 2010 pour tous les enfants âgés de 2 à 60 mois dans le grand hôpital pour enfants de Sanaa. Par rapport à la période précédant la vaccination par le Hib, la période suivant cette dernière a présenté des réductions significatives et remarquables dans les taux d'hospitalisation et de décès pour méningite toutes causes confondues. Toutefois, les taux d'hospitalisation et de décès pour pneumonie très sévère n'ont diminué que modestement. Des éléments montrent certes une tendance à la baisse, mais non significative, et indiquent que la pneumonie très sévère n'était pas un critère d'évaluation spécifique lorsque les étiologies étaient multiples (à la fois virale et bactérienne). La pneumonie très sévère reste la cause principale de morbidité sévère et de décès chez le jeune enfant, notamment chez l'enfant de moins de 12 mois.

bu99-0340.pdf.jpg
Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine / C. Panpitpat ... [et al.]
Panpitpat, Chanatip; Thisyakorn, Usa; Chotpitayasunondh, Tawee; Fürer, Emil; Que, John U; Hasler, Thomas; Cryz, Stanley J ( 2000 )
80(9)690-695.pdf.jpg
Epidemiology of meningitis due to Haemophilus influenzae type b in children in Bulgaria : a prospective, population-based surveillance study / Mira Kojouharova ... [et al.]
Bulgarian Hib Study Team; Kojouharova, Mira; Gatcheva, Nina; Setchanova, Lena; Robertson, Susan E; Wenger, Jay D ( 2002 )
WHO_V-B_01.27_eng.pdf.jpg
Estimating the local burden of Haemophilus influenzae type b (Hib) disease preventable by vaccination : a rapid assessment tool
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
WHO_VRD_GEN_95.05.pdf.jpg
Generic protocol for population-based surveillance of haemophilus influenzae type B / prepared by Orin S. Levine ... [et al.]
Levine, Orin S; Schuchat, Anne; Schwartz, Benjamin; Wenger, Jay D; Elliott, John; WHO Global Programme for Vaccines and Immunization ( 1996 )
WHO_V-B_02.18_eng.pdf.jpg
Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era : a global review of incidence, age distributions, and case-fatality rates
World Health Organization. Dept. of Vaccines and Biologicals ( 2002 )
lau.pdf.jpg
Haemophilus influenzae type B diseases in Asia : editorial / Y.L. Lau
Lau, Y. L ( 1999 )
EMHJ_2001_7_4-5_597_603.pdf.jpg
Haemophilus influenzae type b diseases in children: a pre-vaccination study
Bakir, M.; El Khadir, A.; Devadas, K.; Farrukh, A.S.; Uduman, S.A. ( 2001 )
Abstract

Haemophilus influenzae type b [Hib] can now be prevented by vaccination. We present the clinical and laboratory characteristics of acute invasive H. influenzae diseases in children admitted over a 4-year period to a tertiary paediatric ward of the Al-Ain medical district hospital, before vaccination became available in the United Arab Emirates. In all, 38 children had bacteriologically proven H. influenzae invasive diseases and all the isolates were serotype b. Meningitis was diagnosed in 60.5% of the children and 66% of the studied children were under 12 months. There were no deaths but substantial morbidity occurred in 12 children

Haemophilus influenzae type b immunization : introducing Haemophilus influenzae type B (Hib) conjugate vaccine into national immunization services
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
Inmunización contra Haemophilus influenzae tipo b : introducción de la vacuna conjugada contra Haemophilus influenzae tipo B(Hib) en los servicios nacionales de inmunización
World Health Organization. Dept. of Vaccines and Biologicals ( 2001 )
WHO_BS_2014.2239_eng.pdf.jpg
International collaborative study for the calibration of a replacement international standard for the WHO 1st International Standard for Haemophilus influenzae type b polysaccharide
WHO Expert Committee on Biological Standardization; World Health Organization ( 2014 )
WHO_BS_05.2018_eng.pdf.jpg
International collaborative study to evaluate a candidate international standard for Haemophilus Influenzae type B Capsular Polysaccharide / by Fatme Mawas, Barbara Bolgiano, Danielle Belgrave, Dennis Crane, Peter Rigsby, and Michael J. Corbel
Mawas, Fatme; Bolgiano, Danielle; Crane, Dennis; Rigsby, Peter; Corbel, Michael J; World Health Organization. Biologicals Unit; WHO Expert Committee on Biological Standardization (2005 : Geneva, Switzerland) ( 2005 )
WHO_V-B_00.05_fre.pdf.jpg
Introduction du vaccin anti-Haemophilus influenzae type b dans les programmes de vaccination : principes directeurs pour la gestion et informations à l'intention des agents de santé et des parents
World Health Organization. Dept. of Vaccines and Biologicals ( 2000 )
WHO_V-B_00.05_eng.pdf.jpg
Introduction of Haemophilus Influenzae type b vaccine into immunization programmes : management guidelines, including information for health workers and parents
World Health Organization. Dept. of Vaccines and Biologicals ( 2000 )
WHO_IVB_12.08_eng.pdf.jpg
Measuring impact of streptococcus pneumoniae and haemophilus influenzae type b conjugate vaccination
World Health Organization ( 2012 )
WHO_IVB_12.08F_fre.pdf.jpg
Mesurer l'impact de la vaccination par les vaccins conjugués anti-streptococcus pneumoniae et anti-Haemophilus influenzae type b
Organisation mondiale de la Santé ( 2013 )
RA_2000_2_7-8_fre.pdf.jpg
Les pathologies à Haemophilus influenzae de type b en Asie : éditorial / Y.L. Lau
Lau, Y. L ( 2000 )
Showing results 1 to 20 of 36  next >